NASDAQ:KIDS - Orthopediatrics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$39.58 -1.29 (-3.16 %)
(As of 05/24/2019 06:00 AM ET)
Previous Close$40.87
Today's Range$39.41 - $40.50
52-Week Range$19.04 - $47.82
Volume30,779 shs
Average Volume71,770 shs
Market Capitalization$580.96 million
P/E RatioN/A
Dividend YieldN/A
Beta0.04
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. It offers trauma and deformity procedures; scoliosis procedures for the treatment of spinal deformity; and sports medicine procedures. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$57.56 million
Book Value$5.45 per share

Profitability

Net Income$-12,020,000.00

Miscellaneous

Employees80
Market Cap$580.96 million
Next Earnings Date8/14/2019 (Estimated)
OptionableNot Optionable

Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) issued its quarterly earnings data on Wednesday, May, 8th. The company reported ($0.21) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.04. The company had revenue of $14.66 million for the quarter, compared to the consensus estimate of $14.67 million. Orthopediatrics had a negative net margin of 16.71% and a negative return on equity of 16.43%. View Orthopediatrics' Earnings History.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for Orthopediatrics.

What guidance has Orthopediatrics issued on next quarter's earnings?

Orthopediatrics issued an update on its FY 2019 earnings guidance on Wednesday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $69.646-70.798 million, compared to the consensus revenue estimate of $69.22 million.

What price target have analysts set for KIDS?

4 Wall Street analysts have issued 12 month price objectives for Orthopediatrics' shares. Their predictions range from $30.00 to $44.00. On average, they expect Orthopediatrics' stock price to reach $39.3333 in the next year. This suggests that the stock has a possible downside of 0.6%. View Analyst Price Targets for Orthopediatrics.

What is the consensus analysts' recommendation for Orthopediatrics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics.

What are Wall Street analysts saying about Orthopediatrics stock?

Here are some recent quotes from research analysts about Orthopediatrics stock:
  • 1. According to Zacks Investment Research, "OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. " (5/14/2019)
  • 2. BTIG Research analysts commented, "We maintain our Buy rating and $44 PT following 1Q19 results which saw softer than anticipated Trauma & Deformity sales resulting from weakness in elective deformity procedures. Overall rev. was in-line with BTIG/Street estimates of $14.8M/$14.7M as continued strength in Scoliosis offset T&D softness (~$900k estimated). Despite the 1Q weakness, mgmt. noted that KIDS had not lost share nor seen competitive encroachment and that deformity procedure volumes have come back noticeably in 2Q to date. That said, at KIDS’ multiple we feel shares will be pressured at least until the bounce-back in volume is seen in 2Q. We continue to view a significant market opportunity, a robust pipeline (both organically and inorganically), and limited competition as able to support continued 20%+ growth (here)." (5/10/2019)

Has Orthopediatrics been receiving favorable news coverage?

Headlines about KIDS stock have trended neutral this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Orthopediatrics earned a news sentiment score of 0.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future.

Who are some of Orthopediatrics' key competitors?

What other stocks do shareholders of Orthopediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthopediatrics investors own include Akorn (AKRX), Advanced Micro Devices (AMD), Intel (INTC), AbbVie (ABBV), Boeing (BA), Freeport-McMoRan (FCX), Honeywell International (HON), Nike (NKE), New Residential Investment (NRZ) and ArQule (ARQL).

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the folowing people:
  • Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
  • Mr. Fred L. Hite, CFO & Director (Age 51)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
  • Mr. David R. Bailey, Exec. VP (Age 40)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

Who are Orthopediatrics' major shareholders?

Orthopediatrics' stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (3.41%), Riverbridge Partners LLC (2.55%), FMR LLC (2.32%), Wasatch Advisors Inc. (1.85%), Prospect Capital Advisors LLC (1.40%) and Wells Fargo & Company MN (1.27%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Harold Ruf and Kevin Unger. View Institutional Ownership Trends for Orthopediatrics.

Which institutional investors are selling Orthopediatrics stock?

KIDS stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., FMR LLC, Riverbridge Partners LLC, Royce & Associates LP, Meitav Dash Investments Ltd., Schonfeld Strategic Advisors LLC, Spark Investment Management LLC and Brasada Capital Management LP. Company insiders that have sold Orthopediatrics company stock in the last year include Daniel J Gerritzen and Kevin Unger. View Insider Buying and Selling for Orthopediatrics.

Which institutional investors are buying Orthopediatrics stock?

KIDS stock was bought by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Morgan Stanley, BlackRock Inc., Geode Capital Management LLC, Northern Trust Corp, Conestoga Capital Advisors LLC, Marshall Wace LLP and JPMorgan Chase & Co.. Company insiders that have bought Orthopediatrics stock in the last two years include David R Pelizzon and Harold Ruf. View Insider Buying and Selling for Orthopediatrics.

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $39.58.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $580.96 million and generates $57.56 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.96) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.

What is Orthopediatrics' official website?

The official website for Orthopediatrics is http://www.orthopediatrics.com/.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]


MarketBeat Community Rating for Orthopediatrics (NASDAQ KIDS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  192 (Vote Outperform)
Underperform Votes:  182 (Vote Underperform)
Total Votes:  374
MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Featured Article: What is the Bid-Ask Spread?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel